Disease-Area Clinician — Trial Endpoints & Prescribing | $150-$230/hr Remote
Overview
This is a paid, part-time consulting opportunity for a practicing US-based clinician to lend their expertise to an AI evaluation initiative in the pharma and biotech space. You'll help design and assess scoring frameworks that examine commercial drugs and development pipelines, with a focus on clinical trial outcomes and their practical impact on prescribing. The initial engagement is a short pilot, with the possibility of ongoing work for strong performers.
What You'll Do4
- 1Build and review structured evaluation rubrics for approved drugs and investigational programs
- 2Interpret clinical trial endpoints and determine whether the evidence would meaningfully influence prescribing decisions
- 3Assess the potential real-world adoption of therapies within your specific area of medical expertise
- 4Apply your clinical judgment consistently across the full set of products included in the pilot
Requirements4
- 1Active, board-certified medical doctor (MD or DO) currently practicing in the United States
- 2Deep subject-matter expertise in a specific therapeutic area, backed by hands-on patient care experience
- 3Familiarity with how biotech and pharmaceutical companies structure development programs and clinical evidence
- 4Ability to evaluate clinical data critically and translate findings into practical prescribing insights
Who Should Apply
You're a clinically active physician who knows your therapeutic area inside and out. You're comfortable reading trial data, questioning endpoints, and making nuanced calls about whether evidence would shift how doctors prescribe. You're also interested in improving how AI systems evaluate medical products and are happy to contribute a focused block of time to a high-impact pilot.
Salary Insight
Paid at a rate of $150–$230 per hour for approximately 10–20 hours of work during the pilot phase.
Location
Required Skills
Application Tip
In your application, name your specific therapeutic area and give a concrete example of a clinical trial endpoint you believe is often misinterpreted—this will demonstrate the exact kind of judgment the role requires.
See NearSkill jobs more often in your search
How your application is processed
1Application received
Your resume and details are logged the moment you apply.
2ATS + eligibility screening
We check your profile against the role’s skills, seniority, and requirements.
3Employer sees qualified profiles only
Only candidates who clear screening move forward.
Similar open positions
Explore active roles that match your skills and interests.
Micro1
VerifiedClinician Oncology Hematology Expert for AI Healthcare Project
A remote contractor role for an experienced clinician in oncology or hematology to support a customer project at the intersection of AI and healthcare. You’ll review and author evaluation materials, judge the clinical defensibility of efficacy and safety conclusions, and ensure reported endpoints align with real-world clinical significance. You will translate complex clinical reasoning into clear, guideline-based rationales for non-clinical audiences using your domain knowledge and structured documentation. Key focus areas include dose escalation decisions, adverse event grading, and detailed outcome endpoints across oncology and hematology trials. CTCAE, RECIST, and Lugano criteria are core tools in this work.
Mercor
VerifiedClinical Medicine Domain Expert
A leading AI lab's GenAI team needs a practicing clinician to shape how frontier models reason about real clinical work. You will audit medical knowledge tasks for clinical soundness, write the instruction specs and golden solutions that set the standard for correctness, and design benchmarks that track model improvement. This full-time W-2 role runs through Cincinnatus LLC, with placement inside the client's own tools and workflows. Expect a hybrid schedule in the Bay Area, with on-site days each week, so local residency or a self-funded relocation is required.
Turing
VerifiedMedicine Physician (MD/DO/Doctoral study/PhD)
Turing, a San Francisco-based research accelerator, works with frontier AI labs and global enterprises to advance AI systems. This role puts licensed physicians at the center of evaluating how AI handles clinical reasoning. You will design evaluation methods for real medical problems, drawing on evidence-based medicine, and build assessment approaches that capture the nuance of clinical practice. The engagement is remote and flexible, up to 30 hours per week for one month, with possible extension based on performance.
Mercor
VerifiedClinical / biomedical / pharma Evaluator
A remote role for seasoned clinical, biomedical, or pharmaceutical experts. You’ll review AI-generated documents, spreadsheets, and slide decks to ensure accuracy, rigor, and domain relevance. Expect to apply deep subject matter knowledge to grade outputs, delivering actionable feedback that helps improve content quality. This hourly engagement emphasizes precise assessment and clear communication.
Mercor
VerifiedBiotech Investment Analyst — Drug Asset & Company Assessment
Mercor is teaming up with a biotech and pharma research group to support expert human evaluation, where you'll build and refine rubrics for assessing commercial medications and drug pipelines. This is a paid, part-time pilot gig that could turn into ongoing work as the project grows. If you have deep experience analyzing biotech assets from a specialist-fund perspective, this is a chance to put that expertise to work remotely.
Mercor
VerifiedPreclinical R&D Expert – In-house Drug Development
An AI lab backed by venture capital is building physics-based foundation models for chemistry, materials science, and drug discovery. The lab works with Mercor to bring in hands-on preclinical R&D experts who guide how AI systems interpret real pharmaceutical data. This remote contract runs about 10 hours per week and pairs bench-level scientific judgment with data annotation work. Your feedback on drug development decisions and data quality shapes how models reason about new medicines.